Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze NBIX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate NBIX investment potential.

What is NBIX stock price today?

Get real-time NBIX stock price, historical data, and price charts on Financhill. Track NBIX performance with our advanced analysis tools.

Is NBIX a good investment?

Evaluate NBIX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy NBIX stock?

To buy NBIX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of NBIX?

View detailed market capitalization data and company valuation metrics for NBIX on our comprehensive analysis page.

What is the P/E ratio of NBIX?

Use our fundamental analysis tools to view NBIX P/E ratio and compare valuation metrics with industry peers.

What are NBIX earnings?

View NBIX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Neurocrine Biosciences, Inc. 10K Form

Buy

NBIX
Neurocrine Biosciences, Inc.

Last Price:

$148.69

Seasonality Move:

9.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01	10Q	NBIX/Neurocrine Biosciences, Inc. Quarterly
2023-10-31	10Q	NBIX/Neurocrine Biosciences, Inc. Quarterly
2023-08-01	10Q	NBIX/Neurocrine Biosciences, Inc. Quarterly
2023-05-03	10Q	NBIX/Neurocrine Biosciences, Inc. Quarterly
2022-11-01	10Q	NBIX/Neurocrine Biosciences, Inc. Quarterly
2022-08-04	10Q	NBIX/Neurocrine Biosciences, Inc. Quarterly

Receive NBIX News And Ratings

See the #1 stock for the next 7 days that we like better than NBIX

NBIX Financial Statistics

Sales & Book Value

Annual Sales:	$2.4B
Cash Flow:	$214.3M
Price / Cash Flow:	26.55
Annual Sales:	$30.13
Price / Book:	5.11

Profitability

EPS (TTM):	4.18730
Net Income (TTM):	$428M
Gross Margin:	$2.3B
Return on Equity:	15.8%
Return on Assets:	11.13%

Neurocrine Biosciences, Inc. Earnings Forecast

Key Neurocrine Biosciences, Inc. Financial Ratios

The Gross Profit Margin over the past 29 years for NBIX is 97.56%.
The Selling, General & Administrative Expenses for NBIX have been equal to 42.76% of Gross Profit Margin.
The Research & Development expenses have been 30.04% of Revenue.
The Interest Expense is 37.09% of Operating Income.
The Net Earning history of NBIX is 14.49% of Total Revenues.
Per Share Earnings over the last 29 years have been positive in 15 years.

Neurocrine Biosciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	NBIX
CUSIP:	64125C
Website:	neurocrine.com

Debt

Debt-to-Equity Ratio:	0.16
Current Ratio:	3.38
Quick Ratio:	2.89

Price-to-Earnings

Trailing P/E Ratio:	46.81
Forward P/E Ratio:	16.85

NBIX Technical Analysis vs Fundamental Analysis

Buy

Neurocrine Biosciences, Inc. (NBIX) is a Buy

Is Neurocrine Biosciences, Inc. a Buy or a Sell?

Neurocrine Biosciences, Inc. stock is rated a Buy

The current Neurocrine Biosciences, Inc. [NBIX] share price is $154.06. The Score for NBIX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.